Abstract
Objective - To determine survival times in dogs with right atrial hemangiosarcoma treated by means of pericardectomy and tumor resection, with or without adjuvant chemotherapy, and identify complications associated with treatment. Design - Retrospective study. Animals - 23 dogs. Procedure - Dogs were included only if the diagnosis was confirmed histologically. Results - The most common initial complaints included acute collapse (8 [35%] dogs), anorexia or inappetence (8 [35%]), and lethargy (8 [35%]).The most common physical examination abnormalities included muffled heart sounds (12 [52%] dogs), tachycardia (7 [30%])•, and weak pulses (7 [30%]). Postoperative complications developed in 12 (52%) dogs; however, most complications were minor. Twenty (87%) dogs were discharged from the hospital. Survival time was significantly longer in the 8 dogs that received adjuvant chemotherapy (mean, 164 days; median, 175 days) than in the 15 dogs that did not receive chemotherapy (mean, 46 days; median, 42 days). Dogs that received chemotherapy were significantly younger and had significantly lower WBC counts than did dogs that did not receive chemotherapy. Conclusions and Clinical Relevance - Results suggested that in dogs with right atrial hemangiosarcoma, surgical resection of the tumor was associated with a low complication rate and complications that did arise typically were minor. In addition, use of adjuvant chemotherapy following resection was associated with significantly longer survival times, compared with resection alone.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 575-579 |
| Number of pages | 5 |
| Journal | Journal of the American Veterinary Medical Association |
| Volume | 226 |
| Issue number | 4 |
| DOIs | |
| State | Published - Feb 15 2005 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- veterinary(all)
Cite this
Survival times in dogs with right atrial hemangiosarcoma treated by means of surgical resection with or without adjuvant chemotherapy : 23 Cases (1986-2000). / Weisse, Chick; Soares, Nancy; Beal, Matthew W.; Steffey, Michele A; Drobatz, Kenneth J.; Henry, Carolyn J.
In: Journal of the American Veterinary Medical Association, Vol. 226, No. 4, 15.02.2005, p. 575-579.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Survival times in dogs with right atrial hemangiosarcoma treated by means of surgical resection with or without adjuvant chemotherapy
T2 - 23 Cases (1986-2000)
AU - Weisse, Chick
AU - Soares, Nancy
AU - Beal, Matthew W.
AU - Steffey, Michele A
AU - Drobatz, Kenneth J.
AU - Henry, Carolyn J.
PY - 2005/2/15
Y1 - 2005/2/15
N2 - Objective - To determine survival times in dogs with right atrial hemangiosarcoma treated by means of pericardectomy and tumor resection, with or without adjuvant chemotherapy, and identify complications associated with treatment. Design - Retrospective study. Animals - 23 dogs. Procedure - Dogs were included only if the diagnosis was confirmed histologically. Results - The most common initial complaints included acute collapse (8 [35%] dogs), anorexia or inappetence (8 [35%]), and lethargy (8 [35%]).The most common physical examination abnormalities included muffled heart sounds (12 [52%] dogs), tachycardia (7 [30%])•, and weak pulses (7 [30%]). Postoperative complications developed in 12 (52%) dogs; however, most complications were minor. Twenty (87%) dogs were discharged from the hospital. Survival time was significantly longer in the 8 dogs that received adjuvant chemotherapy (mean, 164 days; median, 175 days) than in the 15 dogs that did not receive chemotherapy (mean, 46 days; median, 42 days). Dogs that received chemotherapy were significantly younger and had significantly lower WBC counts than did dogs that did not receive chemotherapy. Conclusions and Clinical Relevance - Results suggested that in dogs with right atrial hemangiosarcoma, surgical resection of the tumor was associated with a low complication rate and complications that did arise typically were minor. In addition, use of adjuvant chemotherapy following resection was associated with significantly longer survival times, compared with resection alone.
AB - Objective - To determine survival times in dogs with right atrial hemangiosarcoma treated by means of pericardectomy and tumor resection, with or without adjuvant chemotherapy, and identify complications associated with treatment. Design - Retrospective study. Animals - 23 dogs. Procedure - Dogs were included only if the diagnosis was confirmed histologically. Results - The most common initial complaints included acute collapse (8 [35%] dogs), anorexia or inappetence (8 [35%]), and lethargy (8 [35%]).The most common physical examination abnormalities included muffled heart sounds (12 [52%] dogs), tachycardia (7 [30%])•, and weak pulses (7 [30%]). Postoperative complications developed in 12 (52%) dogs; however, most complications were minor. Twenty (87%) dogs were discharged from the hospital. Survival time was significantly longer in the 8 dogs that received adjuvant chemotherapy (mean, 164 days; median, 175 days) than in the 15 dogs that did not receive chemotherapy (mean, 46 days; median, 42 days). Dogs that received chemotherapy were significantly younger and had significantly lower WBC counts than did dogs that did not receive chemotherapy. Conclusions and Clinical Relevance - Results suggested that in dogs with right atrial hemangiosarcoma, surgical resection of the tumor was associated with a low complication rate and complications that did arise typically were minor. In addition, use of adjuvant chemotherapy following resection was associated with significantly longer survival times, compared with resection alone.
UR - http://www.scopus.com/inward/record.url?scp=13744249143&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=13744249143&partnerID=8YFLogxK
U2 - 10.2460/javma.2005.226.575
DO - 10.2460/javma.2005.226.575
M3 - Article
C2 - 15742699
AN - SCOPUS:13744249143
VL - 226
SP - 575
EP - 579
JO - Journal of the American Veterinary Medical Association
JF - Journal of the American Veterinary Medical Association
SN - 0003-1488
IS - 4
ER -